Augmentation with Atypical Antipsychotics for Depression: A Review of Evidence-Based Support from the Medical Literature

Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants

(2016) Robert M. Berman et al.   CNS SPECTRUMS

Neurobiological bases and clinical aspects of the use of aripiprazole in treatment-resistant major depressive disorder

(2011) Pierre Blier et al.   JOURNAL OF AFFECTIVE DISORDERS

Early Weight Gain as a Predictor of Substantial Weight Gain With Olanzapine/Fluoxetine Combination

(2011) Elisabeth K. Degenhardt et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Effect of augmentation with olanzapine in outpatients with depression in partial remission with melancholic features: Consecutive case series

(2011) Koji Nozawa et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder

(2011) Robert Berman et al.   Neuropsychiatric Disease and Treatment

Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study

(2010) Nizar El-Khalili et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials

(2009) J. Craig Nelson et al.   AMERICAN JOURNAL OF PSYCHIATRY

A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder

(2009) Amir Garakani et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Efficacy, safety and tolerability of quetiapine augmentation in treatment resistant depression: An open-label, pilot study

(2009) I.M. Anderson et al.   JOURNAL OF AFFECTIVE DISORDERS

Efficacy of Risperidone Augmentation to Antidepressants in the Management of Suicidality in Major Depressive Disorder

(2009) Hollis Reeves et al.   JOURNAL OF CLINICAL PSYCHIATRY

Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder

(2009) Michael Bauer et al.   JOURNAL OF CLINICAL PSYCHIATRY

The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder

(2009) Ronald N. Marcus et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Use of atypical antipsychotics for treatment-resistant major depressive disorder

(2009) George I. Papakostas et al.   Current Psychiatry Reports

Quetiapine augmentation in depressed patients with partial response to antidepressants

(2008) James S Olver et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Augmentation with olanzapine in TCA-refractory depression with melancholic features: a consecutive case series

(2008) Hitoshi Takahashi et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression

(2008) Gabor I. Keitner et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: Possible involvement of alpha-2 adrenergic receptors

(2008) Ashish Dhir et al.   NEUROSCIENCE LETTERS

Placebo-Controlled Study of Relapse Prevention With Risperidone Augmentation in Older Patients with Resistant Depression

(2007) George S. Alexopoulos et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Aripiprazole as an adjunctive treatment for refractory unipolar depression

(2007) David J. Hellerstein et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY